Nobilis Health Corp.
NRTSF · OTC
12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 4.9% | 24.7% | 172.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 62.4% | 61.6% | 65.9% | 72.4% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 11.4% | 6.7% | 15.9% | 26.2% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 1.3% | 2.3% | 22.2% | 8% |
| EPS Diluted | 0.05 | 0.08 | 0.68 | 0.14 |
| % Growth | -37.5% | -88.2% | 385.7% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | $0 | $0 |